EUVIMEDEUVIMED entdecken
Crossref

Tailored design of NHS–SS–NHS cross-linked chitosan nano-hydrogels for enhanced anti-tumor efficacy by GSH-responsive drug release

Cuiling Ouyang, Minxin Deng, Xiaowei Tan, Ziyi Liu, Tuo Huang, Siyu Yu, Zan Ge, Yafang Zhang, Yujun Ding, Hezhang Chen, Hui Chu, Jian Chen iD

Biomedical Materials · 01.07.2024 · 19 (4) · 045015

DOI: 10.1088/1748-605x/ad4e86 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 30.05.2024. Verfasst von Cuiling Ouyang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, People's Republic of China. Hauptthemen laut MEDLINE: Chitosan, Doxorubicin, Glutathione, Hydrogels. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Scientific Research Fund of Hunan Provincial Education Department, Natural Science Foundation of Hunan Province, China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The traditional chemotherapeutic agents’ disadvantages such as high toxicity, untargeting and poor water solubility lead to disappointing chemotherapy effects, which restricts its clinical application. In this work, novel size-appropriate and glutathione (GSH)-responsive nano-hydrogels were successfully prepared via the active ester method between chitosan (containing –NH 2 ) and cross-linker (containing NHS). Especially, the cross-linker was elaborately designed to possess a disulfide linkage (SS) as well as two terminal NHS groups, namely NHS–SS–NHS. These functionalities endowed chitosan-based cross-linked scaffolds with capabilities for drug loading and delivery, as well as a GSH-responsive mechanism for drug release. The prepared nano-hydrogels demonstrated excellent performance applicable morphology, excellent drug loading efficiency (∼22.5%), suitable size (∼100 nm) and long-term stability. The prepared nano-hydrogels released over 80% doxorubicin (DOX) after incubation in 10 mM GSH while a minimal DOX release less than 25% was tested in normal physiological buffer (pH = 7.4). The unloaded nano-hydrogels did not show any apparent cytotoxicity to A 549 cells. In contrast, DOX-loaded nano-hydrogels exhibited marked anti-tumor activity against A 549 cells, especially in high GSH environment. Finally, through fluorescent imaging and flow cytometry analysis, fluorescein isothiocyanate-labeled nano-hydrogels show obvious specific binding to the GSH high-expressing A549 cells and nonspecific binding to the GSH low-expressing A549 cells. Therefore, with this cross-linking approach, our present finding suggests that cross-linked chitosan nano-hydrogel drug carrier improves the anti-tumor effect of the A 549 cells and may serve as a potential injectable delivery carrier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanDoxorubicinGlutathioneHydrogelsCross-Linking ReagentsAntineoplastic AgentsHumansCell SurvivalDrug LiberationCell Line, TumorA549 CellsDrug CarriersDrug Delivery SystemsDisulfidesDelayed-Action Preparations

Stichwörter der Autor:innen

GSHanti-tumor efficacychitosan nano-hydrogelscross-linkerdisulfide linkage

Substanzen

ChitosanDoxorubicinGlutathioneHydrogelsCross-Linking ReagentsAntineoplastic AgentsDrug CarriersDisulfidesDelayed-Action Preparations

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, People's Republic of China.

ORCID-Profile: Jian Chen

Förderung

  • Scientific Research Fund of Hunan Provincial Education Department
  • Natural Science Foundation of Hunan Province, China
  • National Natural Science Foundation of China
  • National College Students’Innovation and Entrepreneurship Training Program, China

Zitieren

APA

Ouyang, C., Deng, M., Tan, X., Liu, Z., Huang, T., Yu, S., Ge, Z., Zhang, Y., Ding, Y., Chen, H., Chu, H., & Chen, J. (2024). Tailored design of NHS–SS–NHS cross-linked chitosan nano-hydrogels for enhanced anti-tumor efficacy by GSH-responsive drug release. Biomedical Materials, 19(4), 045015. https://doi.org/10.1088/1748-605x/ad4e86

Vancouver

Ouyang C, Deng M, Tan X, Liu Z, Huang T, Yu S, et al. Tailored design of NHS–SS–NHS cross-linked chitosan nano-hydrogels for enhanced anti-tumor efficacy by GSH-responsive drug release. Biomedical Materials. 2024;19(4):045015. doi:10.1088/1748-605x/ad4e86

BibTeX
@article{Ouyang2024,
  author = {Ouyang, Cuiling and Deng, Minxin and Tan, Xiaowei and Liu, Ziyi and Huang, Tuo and Yu, Siyu and Ge, Zan and Zhang, Yafang and Ding, Yujun and Chen, Hezhang and Chu, Hui and Chen, Jian},
  title = {Tailored design of NHS–SS–NHS cross-linked chitosan nano-hydrogels for enhanced anti-tumor efficacy by GSH-responsive drug release},
  journal = {Biomedical Materials},
  year = {2024},
  volume = {19},
  number = {4},
  pages = {045015},
  doi = {10.1088/1748-605x/ad4e86}
}
Kostenlos starten →